Tauriga Sciences Inc. | Income Statement
Fiscal year is April-March. All values USD Thousands.
2014
2015
2016
2017
2018
2019
Sales/Revenue
-
-
-
-
1.20
57.10
Cost of Goods Sold (COGS) incl. D&A
111.30
9.50
9.80
7.00
1.50
38.10
Gross Income
111.30
9.50
9.80
7.00
0.30
19
SG&A Expense
6,142.20
3,704.30
2,027.60
1,541.60
1,972.30
1,102.10
EBIT
-
-
2,037.50
-
1,972.70
1,083.10
Unusual Expense
5,274.10
68.50
153.30
94.50
2,202.60
172.20
Non Operating Income/Expense
-
-
125.00
-
13.10
96.20
Interest Expense
641.10
1,318.20
407.50
721.40
291.60
280.60
Pretax Income
12,168.80
4,963.60
2,473.20
2,175.50
74.80
1,095.20
Consolidated Net Income
12,168.80
4,963.60
2,473.20
2,175.50
74.80
1,095.20
Net Income
12,168.80
4,963.60
2,473.20
2,175.50
36.10
1,095.20
Net Income After Extraordinaries
12,168.80
4,838.20
2,377.20
2,175.50
36.10
1,093
Net Income Available to Common
12,168.80
5,089.00
2,464.20
2,271.30
307.40
1,097.40
EPS (Basic)
2.25
0.75
0.20
0.12
0.01
0.02
Basic Shares Outstanding
4,655.30
10,485.40
12,867.70
19,037.60
37,528.90
55,767.10
EPS (Diluted)
2.61
0.49
0.20
0.12
0.01
0.02
Diluted Shares Outstanding
4,655.30
10,485.40
12,867.70
19,037.60
37,528.90
55,767.10
EBITDA
6,142.20
3,704.30
2,027.60
1,541.60
1,971.90
1,082.10
Minority Interest Expense
-
-
-
-
38.70
-
Preferred Dividends
-
-
-
95.80
271.30
-
About Tauriga Sciences
View Profile
